CFL1 and early-onset autosomal dominant Alzheimer disease: Previously, CFL1 has been implicated in the development of neurodegenerative diseases (Alzheimer’s disease and Huntington’s disease) [67], neuronal migration disorders (lissencephaly, epilepsy, and schizophrenia), neural tube closure defects [68] and memory consolidation during sleep [53].